skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response

Journal Article · · Nuclear Medicine Communications
 [1];  [1];  [1];  [1];  [2];  [3];  [1]
  1. Washington Univ. School of Medicine, St. Louis, MO (United States). Dept. of Radiology
  2. Washington Univ. School of Medicine, St. Louis, MO (United States). Dept. of Radiology, and Dept. of Neurology, Neuroscience, Physical Therapy and Occupational Therapy
  3. Saint Louis Univ. School of Medicine, St. Louis, MO (United States). Dept. of Pharmacological and Physiological Science
+ Show Author Affiliations

OBJECTIVE: The P2X7 receptor (P2X7R) is a key regulatory element in the neuroinflammatory cascade that provides a promising target for imaging neuroinflammation. GSK1482160, a P2X7R modulator with nanomolar binding affinity and high selectivity, has been successfully radiolabeled and utilized for imaging P2X7 levels in a mouse model of lipopolysaccharide-induced systemic inflammation. In the current study, we further characterized its binding profile and determined whether [11C]GSK1482160 can detect changes in P2X7R expression in a rodent model of multiple sclerosis. METHODS: [11C]GSK1482160 was synthesized with high specific activity and high radiochemical purity. Radioligand saturation and competition binding assays were performed for [11C]GSK1482160 using HEK293-hP2X7R living cells. Micro-PET studies were carried out in nonhuman primates. In vitro autoradiography and immunohistochemistry studies were then carried out to evaluate tracer uptake and P2X7 expression in experimental autoimmune encephalomyelitis (EAE) rat lumbar spinal cord at EAE-peak and EAE-remitting stages compared with sham rats. RESULTS: [11C]GSK1482160 binds to HEK293-hP2X7R living cells with high binding affinity (Kd=5.09±0.98 nmol/l, Ki=2.63±0.6 nmol/l). Micro-PET studies showed high tracer retention and a homogeneous distribution in the brain of nonhuman primates. In the EAE rat model, tracer uptake of [11C]GSK1482160 in rat lumbar spinal cord was the highest at the EAE-peak stage (277.74±79.74 PSL/mm), followed by the EAE-remitting stage(149.00±54.14 PSL/mm2) and sham (66.37±1.4 PSL/mm2). The tracer uptake correlated strongly with P2X7-positive cell counts, activated microglia numbers, and disease severity. CONCLUSION: We conclude that [11C]GSK1482160 has the potential for application in monitoring neuroinflammation.

Research Organization:
Washington Univ., St. Louis, MO (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH)
Grant/Contract Number:
SC0008432; SC0012737; NS058714; NS41509
OSTI ID:
1469801
Journal Information:
Nuclear Medicine Communications, Vol. 38, Issue 5; ISSN 0143-3636
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 44 works
Citation information provided by
Web of Science

References (35)

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes journal September 2016
P2X7 receptor: an emerging target in central nervous system diseases journal October 2014
The microglial ATP-gated ion channel P2X7 as a CNS drug target: P2X7 in the CNS journal May 2016
The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore journal March 2009
Altered Cytokine Production in Mice Lacking P2X7Receptors journal January 2001
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models journal June 2016
P2X7 receptor inhibition improves recovery after spinal cord injury journal July 2004
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH journal October 2013
P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease journal April 2003
P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis journal August 2007
Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor journal May 2015
Characterization of 11 C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation journal October 2016
Syntheses and Radiosyntheses of Two Carbon-11 Labeled Potent and Selective Radioligands for Imaging Vesicular Acetylcholine Transporter journal May 2014
HSP90 Regulation of P2X7 Receptor Function Requires an Intact Cytoplasmic C-Terminus journal June 2016
Expression of P2X7 in human hematopoietic cell lines and leukemia patients journal December 2004
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine journal January 2006
Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates journal February 2016
MRI-PET Registration with Automated Algorithm journal January 1993
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis journal March 2016
An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28 journal October 2011
Synthesis and initial preclinical evaluation of the P2X 7 receptor antagonist [ 11 C]A-740003 as a novel tracer of neuroinflammation: Synthesis and initial preclinical evaluation of [ 11 C]A-740003 journal June 2014
Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates journal May 2016
Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor journal September 2010
Cellular localization of P2X7 receptor mRNA in the rat brain journal February 2008
Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat: P2X7 localization, binding and occupancy assay journal December 2010
Substituted 5,6-(Dihydropyrido[3,4- d ]pyrimidin-7(8 H )-yl)-methanones as P2X7 Antagonists journal January 2016
Temporal expression of P2X7 purinergic receptor during the course of experimental autoimmune encephalomyelitis journal December 2010
Experimental autoimmune encephalomyelitis repressed by microglial paralysis journal January 2005
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients journal March 1999
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis journal December 2013
The P2X 7 Receptor: A Key Player in IL-1 Processing and Release journal March 2006
A Key Role for Redox Signaling in Rapid P2X 7 Receptor-Induced IL-1β Processing in Human Monocytes journal June 2008
In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brain journal February 2008
Porphyromonas gingivalis Fimbriae Dampen P2X7-Dependent Interleukin-1β Secretion journal January 2014
P2X7 Receptor-Dependent Blebbing and the Activation of Rho-Effector Kinases, Caspases, and IL-1β Release journal June 2003

Cited By (9)

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography journal March 2018
In vivo Imaging of Glial Activation in Alzheimer's Disease journal August 2018
[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers journal June 2019
Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO journal January 2018
PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation journal January 2019
Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation journal April 2018
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers journal April 2019
PET Imaging of Microglial Activation—Beyond Targeting TSPO journal March 2018
Positron emission tomography imaging in evaluation of MS pathology in vivo journal August 2018

Similar Records

PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Journal Article · Mon Mar 14 00:00:00 EDT 2016 · Molecular Imaging and Biology · OSTI ID:1469801
+4 more
Comparison of [ 11 C]TZ1964B and [ 18 F]MNI659 for PET imaging brain PDE10A in nonhuman primates
Journal Article · Fri Aug 26 00:00:00 EDT 2016 · Pharmacology Research & Perspectives · OSTI ID:1469801
+8 more
Conditioning nerve crush accelerates cytoskeletal protein transport in sprouts that form after a subsequent crush
Journal Article · Fri Mar 01 00:00:00 EST 1991 · Journal of Comparative Neurology; (USA) · OSTI ID:1469801

Related Subjects

38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY
experimental autoimmune encephalomyelitis
neuroinflammation
P2X7 receptor
PET radioligand